However, IDH1 mutations were detected at much higher frequencies (over 70%) in grade II and II gliomas [31-35].; Mutations in the homologous IDH2 gene were also identified (around 5%), predominantly in oligodendroglial tumors [32,35]. The gene discussed is IDH1; the disease is central nervous system cancer.